Call us +91 -7376325889/ 7376335889
Mail
Support
Partners
Careers
Knowledge Center
Downloads
Margin Calculator
Equity
F&O
MF
Online Trading
Open an Account
Back Office
Apply IPO
ABOUT US
SERVICES
MARKETS
Equity
Derivatives
Mutual Fund
IPO
PORTFOLIO
OUR RECOMMENDATIONS
CONTACT US
CALCULATORS
ANNUAL INCOME RANGE
BANK MODIFICATION
MENU
×
HOME
SERVICES
MARKETS
PORTFOLIO
OUR RECOMMENDATIONS
ABOUT US
SERVICES
CONTACT US
CALCULATORS
Online Trading
Open an Account
Back Office
Apply IPO
Equity Analysis
Company Profile
Price
Volume
Analysis
Company Profile
News Analysis
Corporate Action
Other Markets
Detailed Quotes
Detailed Quotes
Company Snapshot
Company Background
Board of Directors
Profit & Loss
Balance Sheet
Quarterly Results
Key Financial Ratios
Share Holding Pattern
Directors Report
Score Board
MF Holdings
Name Change
Company News
Peer Comparison
Monthly High / Low
Price Chart
Consolidated Quarters
FII Holding
Simple & CAGR Growth
Deliverable Volumes
Profit & Loss
Glenmark Pharmaceuticals Ltd
Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value(
)
532296
INE935A01035
848.5800097
NSE Symbol
P/E(TTM)
Mar.Cap(
Cr.)
GLENMARK
15.92
36691.51
EPS(TTM)
Face Value(
)
Div & Yield %:
81.65
1
0.19
Particulars(INCOME)
Mar 2024
(
Cr)
Mar 2023
(
Cr)
Mar 2022
(
Cr)
Mar 2021
(
Cr)
Mar 2020
(
Cr)
Mar 2019
(
Cr)
Sales Turnover
7891.12
8220.66
8141.58
7567.93
6712.63
6304.87
Excise Duty
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
7891.12
8220.66
8141.58
7567.93
6712.63
6304.87
Other Income
6238.36
985.94
1044.96
470.13
625.34
954.61
Stock Adjustments
103.07
31.37
16.13
-5.24
-48.77
-471.81
Total Income
14232.55
9237.97
9202.67
8032.82
7289.20
6787.67
EXPENDITURE :
Raw Materials
3313.19
3427.07
3474.66
2944.53
2617.22
1887.15
Power & Fuel Cost
104.92
95.09
91.34
80.49
90.76
82.99
Employee Cost
1434.78
1346.51
1193.20
1107.40
1072.33
969.98
Other Manufacturing Expenses
375.32
304.66
297.44
267.26
230.03
218.75
Selling & Administrative Expenses
1199.17
1246.10
1062.89
914.37
977.77
992.83
Miscellaneous Expenses
325.15
855.71
349.97
358.30
371.53
353.89
Less : Pre-operative Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
6752.52
7275.13
6469.50
5672.35
5359.63
4505.58
Operating Profit
7480.02
1962.84
2733.18
2360.47
1929.57
2282.08
Interest
277.11
206.82
236.04
265.90
256.39
223.81
Gross Profit
7202.91
1756.02
2497.14
2094.57
1673.18
2058.27
Depreciation
202.16
184.15
159.70
150.82
138.54
106.28
Profit Before Tax
7000.75
1571.87
2337.44
1943.75
1534.64
1951.99
Tax
1049.99
386.93
411.08
343.62
269.24
383.50
Fringe Benefit tax
0.00
0.00
0.00
0.00
0.00
0.00
Deferred Tax
783.46
-23.83
-71.42
-49.31
-89.14
-53.61
Reported Net Profit
5167.29
1208.77
1997.79
1649.45
1354.55
1622.11
Extraordinary Items
3742.26
-369.56
354.02
59.87
14.43
277.16
Adjusted Net Profit
1425.03
1578.33
1643.77
1589.58
1340.12
1344.95
Adjustment below Net Profit
-4.76
0.63
1.61
2.48
-5.42
-3.54
P & L Balance brought forward
16002.82
14863.96
12921.86
11340.47
10059.38
8508.84
Statutory Appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Appropriations
77.22
70.54
57.30
70.54
68.03
68.03
P & L Balance carried down
21088.13
16002.82
14863.96
12921.86
11340.47
10059.38
Dividend
0.00
0.00
0.00
0.00
0.00
0.00
Preference Dividend
0.00
0.00
0.00
0.00
0.00
0.00
Equity Dividend %
250.00
250.00
250.00
250.00
250.00
200.00
Dividend Per Share(Rs)
2.50
2.50
2.50
2.50
2.50
2.00
Earnings Per Share-Unit Curr
183.11
42.84
70.80
58.46
48.00
57.49
Earnings Per Share(Adj)-Unit Curr
183.11
42.84
70.80
58.46
48.00
57.49
Book Value-Unit Curr
814.01
633.57
593.21
524.84
468.73
423.22
Book Value(Adj)-Unit Curr
814.01
633.57
593.21
524.84
468.73
423.22